The Hepatitis B vaccine is produced using recombinant DNA technology. This involves inserting the gene that codes for HBsAg into yeast cells. These cells then produce the HBsAg protein, which is purified and used to create the vaccine. This method ensures that the vaccine contains no live virus, making it safe for use in humans.
